Hyaluronic Acid, Corticosteroid and Electrotherapy in Subacromial Impingement Syndrome

NCT04833738 | Completed

• 1 other identifier: Yuzuncu Yil University
• Study Type: interventional
• Target: 90
• Locations: 0 countries
• Sites: N/A

Brief Summary

Background: Electrotherapy, corticosteroid, and hyaluronic acid have been used to treat subacromial impingement syndrome. However, we need to compare treatment options to provide the optimal results. This study aims to compare the effect of hyaluronic acid, corticosteroid, and electrotherapy in subacromial impingement syndrome. Design: Ninety five patients were randomised into three equal groups according to treatment types. Hyaluronic acid (20 mg/2ml, three times one week apart) or corticosteroid (triamcinolone acetonide, 40 mg/ml, single dose) treatments were applied as subacromial injections. Electrotherapy consisted of 14 sessions TENS (20 min.), hotpack (20 min.) and ultrasound (1.5watt/cm2, 1 MHz, 6 min.). Patients were evaluated before treatment, one and four weeks post end of treatment. Visual Analogue Scale (VAS), range of motion (ROM), and Shoulder Disability Questionnaire (SDQ) were used as outcome measures.

Conditions

Subacromial Impingement; Pain, Shoulder

Outcome Measures

Primary Outcomes (3)

• Visual Analogue Scale

  Higher scores represent higher level of shoulder pain.

  1 min.

• range of motion

  Higher scores represent lower level of shoulder function.

  5 min.

• Shoulder Disability Questionnaire

  Higher scores represent higher level of shoulder pain.

  15 min

Study Arms (3)

Electrotherapy

ACTIVE COMPARATOR

Other: Electrotherapy

corticosteroid

ACTIVE COMPARATOR

Drug: Corticosteroids Triamcinolone Acetonide

hyaluronic acid

ACTIVE COMPARATOR

Drug: Hyaluronic acid

Interventions

Hyaluronic acid DRUG

hyaluronic acid

Corticosteroids Triamcinolone Acetonide DRUG

triamcinolone acetonide, 40 mg/ml, single dose

corticosteroid

Electrotherapy OTHER

electrotherapy

Electrotherapy

Eligibility Criteria

• Age: 20 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• The diagnosis of subacromial impingement syndrome

You may not qualify if:

• Patients aged \<20 or \>50 years or who have the following medical conditions were excluded: physical therapy or injection in the past 6 months, shoulder instability, acute trauma, adhesive capsulitis, psychiatric illness, diabetes mellitus, malignancy.

Sponsors & Collaborators

• Şeyhmus KAPLAN: lead

MeSH Terms

Conditions

Shoulder Impingement Syndrome; Shoulder Pain

Interventions

Hyaluronic Acid; Triamcinolone; Electric Stimulation Therapy

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases; Shoulder Injuries; Wounds and Injuries; Arthralgia; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Glycosaminoglycans; Polysaccharides; Carbohydrates; Pregnadienes; Pregnanes; Steroids; Fused-Ring Compounds; Polycyclic Compounds; Steroids, Fluorinated; Therapeutics; Physical Therapy Modalities; Rehabilitation

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Department of Sports Medicine

Study Record Dates

• First Submitted: April 2, 2021
• First Posted: April 6, 2021
• Study Start: September 11, 2013
• Primary Completion: December 10, 2013
• Study Completion: May 28, 2014
• Last Updated: April 6, 2021

Record last verified: 2021-04

Data Sharing

• IPD Sharing: Will not share